Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 33.05
-0.05 (-0.15%)
May 8, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.6 billion as of May 8, 2026. Its market cap has increased by 22.41% in one year.
Market Cap
4.60B
Enterprise Value
6.20B
Revenue
1.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
33.05
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.60B, an increase of 572.56%. That is a compound annual growth rate of 9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 4.60B | 2.01% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.70B |
| Panion & Bf Biotech | 5.52B |
| UnicoCell Biomed | 5.30B |
| Steminent Biotherapeutics | 5.00B |
| Senhwa Biosciences | 4.59B |
| Pharmosa Biopharm | 4.49B |
| OBI Pharma | 4.48B |
| ACRO Biomedical | 4.35B |